Central dopamine modulates anapyrexia but not hyperventilation induced by hypoxia

Area of Science:

• Neuroscience
• Physiology
• Respiratory System

Background:

• Hypoxia triggers hyperventilation and reduces body temperature (Tb) and metabolism (VO2).
• Central dopamine (DA) release is linked to peripheral chemoreceptor stimulation during hypoxia.
• The role of central DA in mediating hypoxic physiological responses remains unclear.

Purpose of the Study:

• To investigate the role of central dopamine (DA) in mediating ventilatory, thermal, and metabolic responses to hypoxia.
• To test the hypothesis that central DA mediates hypoxic responses by antagonizing DA D2-receptors.

Main Methods:

• Conscious rats underwent intracerebroventricular injection of haloperidol (DA D2-receptor antagonist) or vehicle.
• Ventilation, body temperature (Tb), and oxygen consumption (VO2) were measured during normoxia and hypoxia.
• Physiological parameters were analyzed before and after drug administration and during hypoxic exposure.

Main Results:

• Haloperidol did not alter Tb or VO2 during normoxia but decreased breathing frequency.
• During hypoxia, haloperidol significantly attenuated the decrease in Tb and VO2.
• Hyperventilation persisted despite haloperidol administration, suggesting DA does not mediate this response.

Conclusions:

• Central dopamine (DA) plays a role in regulating thermal and metabolic responses to hypoxia.
• DA is not a common mediator for all hypoxic physiological responses, specifically hyperventilation.
• These findings differentiate the mechanisms underlying ventilatory versus thermal/metabolic adaptations to hypoxia.